Back

Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Experimental therapies for heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Kei Morikawa

Kumamoto University, Kumamoto (Japan)

5 More presentations in this session

Presentation thumbnail
The acute hemodynamic effects of sodium lactate infusion: increased cardiac output and decreased afterload in a randomized trial in pigs
Mr O. Horsdal (Aarhus N, DK)
Abstract Slides Video
Presentation thumbnail
Therapeutic potential of pharmacological inhibition of programmed apoptosis, necroptosis, and ferroptosis in improving left ventricular function in post-myocardial infarction rats
Doctor C. Piamsiri (Chiang Mai, TH)
Abstract Slides Video
Presentation thumbnail
Effects of vericiguat on redox signaling in cardiomyocyte
Doctor T. Harada (Yufu City, JP)
Abstract Slides Video
Presentation thumbnail
Long-acting CRF2 peptide agonist improves cardiac function in a rat heart failure model
Mr Y. Stephan (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor
Doctor J. Rosenmeier (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Experimental therapies for heart failure

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources